WeRide Inc. — Earnings Release 2003

Oct 27, 2003

Listed Company Information

FE PHARMA TECH<00399> - Results Announcement (Summary) Far East Pharmaceutical Technology Co., Limited announced on 27/10/2003: (stock code: 00399 ) Year end date: 30/06/2003 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/07/2002 from 01/07/2001 to 30/06/2003 to 30/06/2002 Note ('000 ) ('000 ) Turnover : 992,961 715,717 Profit/(Loss) from Operations : 238,145 175,608 Finance cost : (2,636) (520) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A (131) Profit/(Loss) after Tax & MI : 175,040 134,739 % Change over Last Period : +29.91 % EPS/(LPS)-Basic (in dollars) : 0.344 per 0.335 per share of HK$0.1 share of HK$0.1 -Diluted (in dollars) : 0.334 per 0.314 per share of HK$0.1 share of HK$0.1 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 175,040 134,739 Final Dividend : 8 cents per share 4.5 cents per per Share of HK$0.10 share of HK$0.10 (i.e. 2 cents per subdivided share of HK$0.025) (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 12/12/2003 to 18/12/2003bdi. Payable Date : 31/12/2003 B/C Dates for Annual General Meeting : 12/12/2003 to 18/12/2003bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remark: EARNINGS PER SHARE The calculation of the basic and diluted earnings per share for the year is based on the following data: 2003 2002 HK$'000 HK$'000 Earnings: Profit attributable to shareholders and earnings for the purposes of basic earnings per share 175,040 134,739 Effect of dilutive potential shares: Redeemable convertible bonds - interest expenses - 520 ---------- ---------- Profit attributable to shareholders and earnings for the purposes of diluted earnings per share 175,040 135,259 ========================== 2003 2002 Number of shares: Weighted average number of shares for the purposes of basic earnings per share 508,932,602 402,331,726 Effect of dilutive potential shares: Share options 15,648,762 16,192,057 Redeemable convertible bonds - 12,035,976 ------------ ------------ Weighted average number of shares for the purposes of diluted earnings per share 524,581,364 430,559,759 ============ ============ The computation of diluted earnings per share for the year ended 30 June 2003 does not assume the conversion of the Company's outstanding warrants since its exercise would result in an increase in earnings per share for the year.